Immuno-Oncology
Myeloma highlights at ASH 2022: improving access to CAR-T therapy & future outlooks
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans,…
Date: 3rd January 2023
Highlights in MDS at ASH 2022: treating lower-risk & higher-risk disease, trial updates, & more
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans,…
Date: 21st December 2022
iwNHL Session V: novel therapies in NHL – the role of ADCs
The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in…
Date: 16th December 2022
iwAL 2022 Session V: mechanisms of resistance to targeted therapies in AML
The 4th International Workshop on Acute Leukemias (iwAL) 2022 took place in Nice, France, and brought together leading experts in the…
Date: 6th December 2022
The importance of genomic testing in CLL and its role in clinical decision-making
Chronic lymphocytic leukemia (CLL) remains a challenging hematological malignancy to treat, and genomic testing has become increasingly important in this…
Date: 2nd December 2022
iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells
The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in…
Date: 30th November 2022
Key updates in CLL: novel treatment strategies, the changing role of chemotherapy, and more
The treatment landscape of chronic lymphocytic leukemia (CLL) has transformed over the years with the increased use of Bruton’s tyrosine…
Date: 25th November 2022
iwAL 2022 Session IV: the evolving treatment landscape in ALL and the growing role of immunotherapies
The 4th International Workshop on Acute Leukemias (iwAL) 2022 took place in Nice, France, and brought together leading experts in the…
Date: 22nd November 2022
iwNHL Session III: exploring the optimal management of R/R follicular lymphoma in an expanding treatment landscape
The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in…
Date: 18th November 2022
iwAL 2022 Session III: novel targets, combinations and treatment strategies in AML
The 4th International Workshop on Acute Leukemias (iwAL) 2022 took place in Nice, France, and brought together leading experts in the…
Date: 16th November 2022
Recent updates in CML: treatment strategies, clinical trials, and novel agents
The 10th Annual Meeting of the Society of Hematologic Oncology (SOHO) was held in Houston, TX, from September 28-October 1,…
Date: 11th November 2022
iwNHL Session II: understanding and harnessing the immune microenvironment against lymphoma
The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in…
Date: 9th November 2022